Publications in collaboration with researchers from Fundación Jiménez Díaz (69)

2023

  1. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

    Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057

2022

  1. Bone marrow activation in response to metabolic syndrome and early atherosclerosis

    European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828

2021

  1. Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model

    Journal of Cardiovascular Translational Research, Vol. 14, Núm. 1, pp. 150-160

2020

  1. Quantitative assessment of myocardial blood flow and extracellular volume fraction using 68Ga-DOTA-PET: A feasibility and validation study in large animals

    Journal of Nuclear Cardiology, Vol. 27, Núm. 4, pp. 1249-1260

2019

  1. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1371-1382

2014

  1. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

2004

  1. Virus-Specific Effector CD4+ T-Cell Responses in Hemodialysis Patients with Hepatitis C Virus Infection

    Journal of Medical Virology, Vol. 72, Núm. 1, pp. 66-74

2003

  1. Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease

    Archives of Neurology, Vol. 60, Núm. 9, pp. 1218-1222

  2. Niveles de proteína tau y β-amiloide en la demencia con cuerpos de Lewy en comparación con la enfermedad de Alzheimer

    Mapfre Medicina, Vol. 14, Núm. 2, pp. 118-124

2002

  1. Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates

    Parkinsonism and Related Disorders, Vol. 8, Núm. 5, pp. 311-323

  2. Features of the CD4+ t-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels

    Journal of Hepatology, Vol. 36, Núm. 3, pp. 408-416

  3. Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation

    Journal of Alzheimer's Disease, Vol. 4, Núm. 5, pp. 399-404

  4. Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein

    Movement Disorders, Vol. 17, Núm. 6, pp. 1374-1380

2001

  1. Expression of factor VII in the liver of patients with liver disease: Correlations with the disease severity and impairment in the hemostasis

    Blood Coagulation and Fibrinolysis, Vol. 12, Núm. 3, pp. 193-199

2000

  1. Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: Evaluation of the bleeding risk

    Blood Coagulation and Fibrinolysis

  2. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients

    Hepatology, Vol. 31, Núm. 2, pp. 502-506

  3. Randoimized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis C

    Cytokine, Vol. 12, Núm. 2, pp. 165-170

  4. Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease

    Cytokine, Vol. 12, Núm. 8, pp. 1248-1252

1999

  1. Cinetica del interferon α-2a en pacientes en hemodialisis

    Nefrologia, Vol. 19, Núm. 3, pp. 268-270

  2. In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus

    Journal of Infectious Diseases, Vol. 180, Núm. 2, pp. 262-267